Vitrolife Group
October 26, 2026
Vitrolife Group has appointed Elin Frostehav as President and CEO, effective no later than May 1, 2027. She currently serves as President of Acute Care Therapies and a member of the Executive Team at Getinge, and has previously held senior roles at Semcon and FlexLink. Bronwyn Brophy O'Connor will step down as CEO on November 1, 2026, when Rickard Ericsson, Senior Vice President Innovation, will take over as interim President and CEO until Frostehav assumes the role. This summary was AI-generated.
Source:
Vitrolife Group